Form 4 for QTEX QTREX Quantum Ltd.
Accepted 2026-07-14 17:40:56 ET · period of report 2026-07-06 · accession 0001185185-26-002967 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-14 17:40 | 2026-07-06 | QTEX | Tehila Yafit | CFO | A - Grant | $0.00 | +550.0K | 1.42M | +63% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-07-06 | A | A | 550,000 | $0.00 | 1,420,000 | D | — | — | (F1) The Restricted Share Units ("RSUs") were granted under Qtrex Quantum Ltd.'s (formerly Insense Medical) 2019 Plan, and will vest according to the following schedule: 183,334 RSUs will vest on July 1, 2027, and the remaining RSUs will vest on a quarterly basis over two years following the first vesting event. |